| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 04/10/1996 | EP0705278A1 Apoptose inhibitor |
| 04/10/1996 | EP0705270A1 Chemically modified oligonucleotide for site-directed mutagenesis |
| 04/10/1996 | EP0705264A1 Carbo-acyclic nucleoside derivatives as antiviral and antineoplastic agents |
| 04/10/1996 | EP0705109A1 Adjuvants for vaccines against respiratory syncytial virus |
| 04/10/1996 | EP0705103A1 Use of triterpenesaponins, such as notoginsenoside r1 (r1) and/or astragaloside (iv) for preparing medicaments |
| 04/10/1996 | EP0649429A4 Heteroatomic oligonucleoside linkages. |
| 04/10/1996 | EP0547079B1 New use of a monoclonal antibody |
| 04/10/1996 | EP0484438B1 Biological preparation and its use |
| 04/10/1996 | EP0448697B1 Vitamin a analogues and their applications, in particular as cytotrophic and cytoprotective molecules, and pharmaceutical compositions containing same |
| 04/10/1996 | CN1120353A Anti-microbial agents and screening method therefor |
| 04/10/1996 | CN1120352A Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
| 04/10/1996 | CN1120338A Unsaturated phosphonates derivatives of purines and pyrimidines |
| 04/10/1996 | CN1120316A HIV protease inhibitors in pharmaceutical combinations for the treatment of AIDS |
| 04/10/1996 | CN1120045A New cephalosporins containing in position 7 a substituted benzyloxyimino radical, their preparation process, their use as medicaments |
| 04/10/1996 | CN1120044A Preparation of N-9 substituted guanine compounds |
| 04/09/1996 | US5506355 Method for preparing cyclic sulfamides and their use for the synthesis of HIV protease inhibitors |
| 04/09/1996 | US5506242 Arylsufonamido-substituted hydroxamic acids |
| 04/09/1996 | US5506235 Quinoline derivatives as immunostimulants |
| 04/09/1996 | US5506233 Desosamino derivatives of macrolides as immunosuppressants and antifungal agents |
| 04/09/1996 | US5506225 Antibacterial penem compounds |
| 04/09/1996 | US5506207 GNRH antagonists XIII |
| 04/09/1996 | US5506139 Vaccines, immunology |
| 04/09/1996 | US5506132 Monoclonal antibodies or binding fragments thereof |
| 04/09/1996 | US5505947 Attenuating mutations in Venezuelan Equine Encephalitis virus |
| 04/05/1996 | CA2159547A1 Quinolone- and naphthyridonecarboxylic acid derivatives |
| 04/04/1996 | WO1996010086A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 04/04/1996 | WO1996010035A1 Inhibitors of farnesyl-protein transferase |
| 04/04/1996 | WO1996010019A1 Imidazole derivative |
| 04/04/1996 | WO1996009837A1 Muramyl peptide compositions for inhibiting hiv replication |
| 04/04/1996 | WO1996009832A1 Dna-rna hydrid and a dna preparation, methods of obtaining said hybrid and preparation from sturgeon milt, and a pharmaceutical compound based on said dna-rna hybrid |
| 04/04/1996 | WO1995030763A3 Retroviral vectors having a reduced recombination rate |
| 04/04/1996 | DE4441483C1 Use of bio-assimilated boron cpds. |
| 04/04/1996 | CA2200993A1 Compositions of muramyl peptides inhibiting the replication of hiv |
| 04/04/1996 | CA2200973A1 Glycosyltransferases for biosynthesis of oligosaccharides, and genes encoding them |
| 04/03/1996 | EP0704445A1 Preparation of N-9 substituted guanine compounds |
| 04/03/1996 | EP0704443A2 Quinolone and naphthyridone carboxylic acid derivatives |
| 04/03/1996 | EP0704220A1 Use of medicine containing beta interferon |
| 04/03/1996 | EP0704202A1 Anti-cariogenic agent |
| 04/03/1996 | EP0703925A1 Production of antibody fragments |
| 04/03/1996 | EP0703786A1 Use of nona- and decapeptides in the preparation of a drug for the treatment of aids |
| 04/03/1996 | EP0703784A1 Release and mobilisation of haematopoietic cells |
| 04/03/1996 | EP0703782A1 H2-antagonists as immune stimulants in bacterial infections of cattle or swine |
| 04/03/1996 | EP0703725A1 Method of killing fungi, yeast or bacteria with selected monocyclic monoterpenes |
| 04/03/1996 | CN1119856A Inhibitors of HIV reverse transcriptase |
| 04/03/1996 | CN1119829A Vaccine compositions containing 3-O deacylated monophosphoryl lipid a |
| 04/03/1996 | CN1119649A Glycopeptide antibiotic derivatives |
| 04/03/1996 | CN1119647A 6-membered nitrogen-containing heteroaryl-oxazolidinones |
| 04/03/1996 | CN1119531A A stably storable and readily water soluble composition of cephalosporin for injections |
| 04/02/1996 | US5504194 Lymphocyte adhesion receptor for high endothelium, CD44 |
| 04/02/1996 | US5504189 Peptides, their preparation and use |
| 04/02/1996 | US5504093 Administering a carbostyril derivative |
| 04/02/1996 | US5504081 Administering nicotinergic acetylcholine receptor antagonists and agonists |
| 04/02/1996 | US5504065 Agent for treating or preventing AIDS using human urine trypsin inhibitor |
| 04/02/1996 | US5504005 Recombinant mycobacterial vaccine |
| 04/02/1996 | US5503997 A process for producing legionella specific antibiotic using Streptomyces sp. AL91 |
| 04/02/1996 | US5503973 Method for inhibition of viral morphogenesis |
| 04/02/1996 | US5503853 Prophylactic and therapeutic applications of peroxidases |
| 03/31/1996 | CA2159257A1 Interleukin-1 production inhibiting compound |
| 03/28/1996 | WO1996009405A1 Treatment of plasmodium |
| 03/28/1996 | WO1996009390A2 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 03/28/1996 | WO1996009375A1 Dna encoding human papillomavirus type 6a |
| 03/28/1996 | WO1996009321A1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
| 03/28/1996 | WO1996009074A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | WO1996009071A1 Conjugate consisting of an active substance and a non-exogenous native protein |
| 03/28/1996 | WO1996009068A1 Photodynamic therapy in selective cell inactivation in blood and treating immune dysfunction diseases |
| 03/28/1996 | WO1996009063A1 Use of muramyl peptide compounds |
| 03/28/1996 | DE4433890A1 Konjugat aus einem Wirkstoff und einem nicht als körperfremd angesehenen, nativen Protein Conjugate of an active agent and a non-prestigious as foreign, native protein |
| 03/28/1996 | CA2200835A1 Use of a non-mammalian dna virus to express an exogenous gene in a mammalian cell |
| 03/28/1996 | CA2200570A1 Use of muramyl peptide compounds |
| 03/28/1996 | CA2199748A1 A novel fungal multisubunit protein complex critical for expression of fungal proteins |
| 03/27/1996 | EP0702724A1 Mengovirus as a vector for expression of foreign polypeptides |
| 03/27/1996 | EP0702723A1 Biocompatible implant for the expression and secretion in vivo of a therapeutical compound |
| 03/27/1996 | EP0702716A1 Ribozyme gene therapy for hiv infection and aids |
| 03/27/1996 | EP0702693A1 Tandem synthetic hiv-1 peptides |
| 03/27/1996 | EP0702669A1 Novel antiviral agents |
| 03/27/1996 | EP0702565A1 CATALASE-BASED ANTI-$i(HELICOBACTER PYLORI) IMMUNISING COMPOSITION |
| 03/27/1996 | EP0702564A1 Novel attenuated pseudomonas aeruginosa strains |
| 03/27/1996 | EP0702560A1 Immunologic enhancement with intermittent interleukin-2 therapy |
| 03/27/1996 | EP0593506B1 Lipoaminoacids, preparation method and applications |
| 03/27/1996 | EP0509989B1 Method of preparing ribonuclease dimers |
| 03/27/1996 | CN1119458A Nucleic acid pharmaceuticals |
| 03/27/1996 | CN1119442A Protein Rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition |
| 03/27/1996 | CN1119441A AZA cyclohexapeptide compounds |
| 03/27/1996 | CN1119406A Mucosal competitive exclusion flora |
| 03/27/1996 | CN1119111A Garlic extract capsule and garlic powder capsule, and producing process thereof |
| 03/26/1996 | US5502210 1H-isoindole-1,3-dione compounds |
| 03/26/1996 | US5502193 2-substituted tertiary carbinol derivatives of 1,5-iminosugars |
| 03/26/1996 | US5502183 Steroid intermediates and processes for their preparation |
| 03/26/1996 | US5502075 Leukotriene-B4 derivatives, process for their production and their use as pharmaceutical agents |
| 03/26/1996 | US5502072 Substituted oxindoles |
| 03/26/1996 | US5502061 Peptidyl substituted benzamides and naphthamies |
| 03/26/1996 | US5502060 HIV protease inhibitors |
| 03/26/1996 | US5502033 Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases |
| 03/21/1996 | WO1996008574A1 Novel implant and novel vector for the treatment of acquired diseases |
| 03/21/1996 | WO1996008569A2 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof |
| 03/21/1996 | WO1996008509A1 Anti-fungal peptides |
| 03/21/1996 | WO1996008503A1 Intermediates for dinucleotide and oligonucleotide analogues |
| 03/21/1996 | WO1996008460A1 Legionella specific antibiotic, a microorganism producing the antibiotic and a process for producing the same |
| 03/21/1996 | WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
| 03/21/1996 | WO1996008266A1 Aza cyclohexapeptide compounds |